Sensei Biotherapeutics is abandoning its sole clinical-stage drug and warning of imminent layoffs as the company mulls its ...

Get the latest federal technology news delivered to your inbox. The congressional working group on the national security ramifications of biotechnology is angling to publish and deliver new policy ...

One of the top fundraisers of 2024 is halving its workforce about a year after drawing in a $325 million series C. Cell therapy biotech Arsenal Biosciences has laid off about 50% of its staff as it ...

As investors prepare for the Federal Reserve to raise interest rates, the health IT and biotechnology sectors have lost momentum and suffered losses, Nasdaq reported Jan. 30. The Nasdaq biotechnology ...